MeTHODs
Twenty non-small cell lung cancer patients were scanned twice with A major obstacle to the introduction of PeT measures into response criteria such as reCisT is the lack of evidence beyond proof of principle. Because of the relatively small sample size of most observational PeT studies, meta-analysis would be beneficial but is hampered by methodologic heterogeneity, especially in acquisition, reconstruction, and data-analysis methods. Awareness that standardization of procedures is a key issue has only recently seemed to grow [6] . repeatability (a function of biologic, technical, and observer variation) is an important feature of response-evaluation tools.
Knowledge of normal variation helps to identify the relevant change in parameter value caused by an intervention. [7, 8] , and for full detail we refer to those publications. scans were obtained on an eCAT eXACT Hr+ scanner (siemens/CTi). A 10-to 15-min transmission scan was followed by a 60-min emission scan in 2-dimensional mode [9] . At the start of the dynamic 60-min emission scan, a bolus injection of 370 MBq of [ in addition to this phantom experiment, a second experiment was performed using the same phantom to assess the repeatability of observed metabolic volumes. The background compartment was filled with an [
18 F]FDg solution (2 kBq/mL), and the spheres were filled so that an sBr of 9 was obtained. An identical experiment, with an sBr of 4.5 was performed. These phantoms were each scanned 6 times using the same scanner (Hr+), procedure, and reconstruction parameters as applied during patient studies. For each of the 6 experiments, the phantoms were positioned at (slightly) different locations in the scanner. in this way, the axial slices and image matrix will cut through or sample the spheres differently during each study, thereby resembling the conditions met during clinical studies.
iMAge AnALYsis
For VOi definition, a semiautomatic delineation tool was used, applying predefined thresholds of the maximum voxel value within the tumor [6, 10] . in this study, 4
predefined threshold VOis consisting of 41%, 50%, and 70% of the maximum voxel value, with correction (adaption) for local background (A41%, A50%, and A70%, respectively), and a 50% uncorrected threshold VOi of the maximum voxel value (50%) were used to define the lesion volume. rather than showing results for a single (optimal) threshold, we chose to use several VOis to illustrate the effect of different VOi thresholds on volumetric accuracy, precision, and success rate. The 4 volumes ( Figure 5 .1) were analyzed after a visual check, to ensure that nontumor tissue was not included. All evaluable lesions in the field of view that had adequate focal uptake and were thus delineable with the semiautomatic VOi tool for at least 1 of the studied VOi methods were included.
For the phantom experiment, VOis equal to those described for the patient study were used. Volume recovery coefficients were obtained by dividing the observed VOis by the true phantom sphere volumes. Volume recovery coefficients were plotted as a function of true sphere volume and sBr. in addition, the repeatability of observed volumes seen during the second series of experiments will be reported.
sTATisTiCAL AnALYsis
The repeatability of the measurements was estimated by calculating the mean and sD of the difference between test and retest values. in addition, the percentage difference was calculated as the absolute value of the difference between test and retest values, divided by the mean of both measurements. For both quantities, the repeatability coefficient (rC) was calculated as 1.96 x sD, as adopted by the British standards institution [11] . Assuming that data are normally distributed with a mean of 0, in 95% of the cases the difference between the 2 measurements will be less than the rC. The impact of clustered observations (multiple pairs of measurements of different lesions on the same subject) was studied by means of mixed-effects models and, if necessary, corrected [12, 13] . it was found that an A41% threshold most closely provided true sphere volume for spheres larger than 17 mm in diameter (or 2.6 mL), especially for an sBr of 4.5. Yet, for small spheres all methods, including the A41% threshold, seem not to provide reliable sphere volumes (and thus these points are missing in Figure 5 .2). When the sBr equaled 9, VOi A41% still provided the most accurate sphere volumes, although some bias up to 220% was observed. Use of higher threshold values (A50%-A70%)
obviously results in smaller volume recovery coefficients. Yet, these higher thresholds are included in the patient studies because we hypothesized that relatively low thresholds may be more sensitive to lesion and non tumor uptake heterogeneity.
results
FigUre 5.2 Plot of volume recovery coefficients per sphere volume in phantom study for different thresholds (same thresholds applied for patient study) with sBrs of 4.5 (A) and 9 (B). in both A and B, VOi A41%, 50%, A50%, and A70% (upper to lower datasets) are
represented by ■, , , and •, respectively.
in Table 5 .1, the coefficient of variation (COV %) of observed volumes is given for each of the VOi methods studied. in general, COV increases with smaller VOis (or with higher VOi thresholds), for lower sBrs and smaller spheres. in Table 5 .2, the sDs of observed volumes are shown. in this case, sD seems to decrease for smaller spheres, but a change of sD with higher-threshold VOi showed a less clear trend. improved the metabolic volume reproducibility obtained with an A50% threshold from an rC of 73% to an rC of 16%.
Metabolic volumes derived from VOis that were based on a relative threshold of the maximum standardized uptake value (sUV) could depend on maximum sUV or mean sUV itself. However, no correlation between metabolic volume test-retest and maximum sUV test-retest variabilities was observed (r 2 = 0.0002 and 0.13 for For clinical implementation of any parameter of response assessment, test-retest repeatability has to be known. in this study, we explored 4 currently often-used VOi methodologies in lung cancer. From the array of VOi methods, we prefer semiautomatic delineation for reasons of consistency, lack of observer variability, and practical standpoints [8] . Many sophisticated and sometimes complicated VOi methods are being developed, in part driven by the demand for radiotherapy planning. results observed in the phantom studies closely corresponded to those found elsewhere-that is, for lung cancer ([ 18 F]FDg) PeT studies a threshold close to 41%-50% has been reported to provide accurate tumor volumes [14] . Obviously, higher thresholds and sBrs will provide smaller measured volumes, as seen both in the phantom and the patient studies. 
discussion
Change in COV and sD of observed VOis in the phantom study seem to follow the same trends as seen in the clinical studies. Higher-threshold VOis provided smaller volumes and larger COVs, as was seen for both the [ Moreover, COV seems to worsen for smaller spheres and for lower sBrs. Yet, COV results seemed to be better-that is, a lower COV-than those seen in clinical studies.
A possible explanation could be that the uptake in the sphere and background is homogeneous, whereas this is clearly not the case in patient studies. (e.g., gradient-based and iterative) on the accuracy and precision of metabolic volume assessments need to be evaluated. The performance of many VOi methods likely depends on or requires optimization of PeT image acquisition. Therefore, it is also important to strive for standardized PeT measurements [6, 16] . Our VOi methods use a relative threshold of the maximum sUV and capture the metabolically most active part of the tumor only. This may be justified when PeT is used to assess response to chemotherapy, assuming that the metabolically most active part of the tumor is the most relevant one. in the case of heterogeneous uptake, parts of the tumors will be missed (or oversegmented) using threshold-based methods. monitoring, these test-retest boundaries should be taken into account. Considering the balance between success rate and repeatability of true tumor volume, using a VOi A50% threshold seems the most optimal and widely available or applicable of the tested VOi methods. We thank the patients and their families for participating in this study. in addition, we acknowledge the staff of the Department of nuclear Medicine and PeT research of the VU University Medical Centre, Amsterdam, The netherlands, for their help with tracer production and data collection.
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